The improvement in survival was associated with a marked in vivo depletion in ATR, CHK1 and RAD52, but induction of γ-H2AX, cleaved Caspase 3 and BIM in the engrafted tumor cells following 1 week of treatment with the combination. This evidence concerns the gene BCL2L11 and neoplasm.